Pharmacological profiles of opioid ligands at Kappa opioid receptors
2006

Pharmacological Profiles of Opioid Ligands at Kappa Opioid Receptors

publication Evidence: moderate

Author Information

Author(s): Gharagozlou Parham, Hashemi Ezzat, DeLorey Timothy M, Clark J David, Lameh Jelveh

Primary Institution: Department of Pharmacology, Molecular Research Institute, Mountain View, CA, USA

Hypothesis

The study aims to describe the activity of a set of opioid drugs in a human embryonic kidney cell system expressing only the mouse κ-opioid receptors.

Conclusion

The study elucidates the relative activities of a set of opioid ligands at κ-opioid receptors, providing a foundation for understanding their mode of action.

Supporting Evidence

  • Naltrexone, WIN 44,441, and dezocine were classified as antagonists.
  • Fentanyl was identified as the ligand with the highest intrinsic activity.
  • Nalbuphine exhibited partial agonist activity at κ-opioid receptors.

Takeaway

This study looks at how different opioid drugs work on a specific receptor in cells, helping us understand how they might be used for pain relief.

Methodology

The study used HEK293 cells stably expressing κ-opioid receptors to assess the binding affinity and activation potency of fifteen opioid ligands.

Limitations

The study's findings may not fully represent in vivo conditions as HEK cells are not neuronal and lack some intracellular machinery.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2210-6-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication